Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management

SYC Tong, JS Davis, E Eichenberger… - Clinical microbiology …, 2015 - Am Soc Microbiol
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Mechanisms of antimicrobial resistance in Gram-negative bacilli

É Ruppé, PL Woerther, F Barbier - Annals of intensive care, 2015 - Springer
The burden of multidrug resistance in Gram-negative bacilli (GNB) now represents a daily
issue for the management of antimicrobial therapy in intensive care unit (ICU) patients. In …

Management of pneumonia in critically ill patients

C Cillóniz, A Torres, MS Niederman - bmj, 2021 - bmj.com
Severe pneumonia is associated with high mortality (short and long term), as well as
pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of …

Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns

C Cilloniz, I Martin-Loeches, C Garcia-Vidal… - International journal of …, 2016 - mdpi.com
Globally, pneumonia is a serious public health concern and a major cause of mortality and
morbidity. Despite advances in antimicrobial therapies, microbiological diagnostic tests and …

An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance

ST Micek, RG Wunderink, MH Kollef, C Chen, J Rello… - Critical Care, 2015 - Springer
Introduction Pseudomonas aeruginosa nosocomial pneumonia (Pa-NP) is associated with
considerable morbidity, prolonged hospitalization, increased costs, and mortality. Methods …

Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients

MI Restrepo, BL Babu, LF Reyes… - European …, 2018 - Eur Respiratory Soc
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to
the antibiotics used most frequently in patients with community-acquired pneumonia (CAP) …

Severe community-acquired pneumonia

MS Niederman, A Torres - European Respiratory Review, 2022 - Eur Respiratory Soc
Severe community-acquired pneumonia is the most life-threatening form of community-
acquired pneumonia, characterised by intensive care unit admission and high morbidity and …

Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies

JA Ramirez, DM Musher, SE Evans, CD Cruz… - Chest, 2020 - Elsevier
Background Community-acquired pneumonia (CAP) guidelines have improved the
treatment and outcomes of patients with CAP, primarily by standardization of initial empirical …

Prevalence and etiology of community-acquired pneumonia in immunocompromised patients

MF Di Pasquale, G Sotgiu, A Gramegna… - Clinical Infectious …, 2019 - academic.oup.com
Background The correct management of immunocompromised patients with pneumonia is
debated. We evaluated the prevalence, risk factors, and characteristics of …

Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns

M Assefa - Pneumonia, 2022 - Springer
Bacterial pneumonia is one of the most serious public health issues owing to its medical and
economic costs, which result in increased morbidity and mortality in people of all ages …